Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-30.67	50.61	73.00
Graham Fair Price	-41.54	10.13	17.33
PEG	797.94	-0.33	0.04
Price/Book	-6.80	2.37	2.54
Price/Cash Flow	572.55	-72.21	10.74
Prices/Earnings	237.40	23.15	6.86
Price/Sales	179.58	7.21	2.58
Price/FCF	572.55	-72.21	10.74
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	61292.05	0.25	< 0.005
Operating Margin	26056.08	0.11	< 0.005
ROA	-71.15	0.01	0.04
ROE	0.09	0.03	-72.38
ROIC	< 0.005	0.02	8633.36
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.16	-0.04	279.63
Dividends QOQ	-0.09	-1.00	-996.97
EBIT QOQ	-0.99	95.55	9538.53
EPS QOQ	1.85	-0.69	-62.42
FCF QOQ	16.78	-1.15	-93.12
Revenue QOQ	1.52	-0.63	-58.49
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	25.46	113.84	347.11
Days Sales Outstanding (DSO)	13.75	30.81	124.01
Inventory Turnover	3.53	0.79	-77.63
Debt/Capitalization	0.33	0.34	3.01
Quick Ratio	1.39	0.91	-34.11
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12.01	13.36	11.23
Cash	9.35	5.95	-36.35
Capex	-0.37	-0.14	60.60
Free Cash Flow	2.84	-0.44	-84.59
Revenue	11.83	4.39	-62.92
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.87	1.68	-9.97
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-6.34	1.32	-79.12
Naive Interpretation	Member

06 - Financial Health · Weak

Rating